Skip to main content
. 2006 Feb;117(2):262–270. doi: 10.1111/j.1365-2567.2005.02294.x

Figure 2.

Figure 2

Constraints of treatment with EtxB 10–12-week old female NOD mice (12 per group) were treated either intranasally or subcutaneously with 10 µg EtxB(a; ○), with 10 10 µg EtxB(G33D)(b;•) or were given PBS alone (▪) on the number of occasions indicated. Diabetes was diagnosed on the basis of weekly urinary glucose testing